Wilson, Aaron S.
Triller, Darren M. http://orcid.org/0000-0002-0464-7448
Allen, Arthur
Burnett, Allison
Gouveia-Pisano, Julie Ann
Brenner, Allison
Pritchard, Barbara
Medico, Charles
Vazquez, Sara R.
Witt, Dan M.
Barnes, Geoffrey D.
Funding for this research was provided by:
Pfizer
Article History
Accepted: 29 July 2023
First Online: 18 August 2023
Declarations
:
: This initiative was a collaboration between Anticoagulation Forum and Pfizer Inc and the initiative and manuscript were funded by the Bristol Myers Squibb and Pfizer Inc. Alliance. Julie Ann Gouveia-Pisano, Allison Brenner, Barbara Pritchard, and Charles Medico are employees and shareholders of Pfizer Inc. Arthur Allen: Speakers Bureau for Astra Zeneca, Alexion, and Janssen; Consulting/Ad Boards for Pfizer and BMS. Board of Directors for Anticoagulation Forum. The contents of this manuscript do not represent the views of VHA or the United States Government. Allison Burnett: Honoraria from Wolters-Kluwer, Pharmacy Times; Royalties from Up to Date; Consultant for Abiomed; Board of Directors for Anticoagulation Forum, Board of Directors for National Certification Board for Anticoagulation Providers. Geoffrey Barnes: Consulting fees from Pfizer, Bristol-Myers Squibb, Janssen, Boston Scientific, Abbott Vascular, Bayer. Board of Directors for Anticoagulation Forum. Aaron Wilson: None to disclose. Daniel Witt: Research funding from Roche Diagnostics and supported by a grant from Agency for Healthcare Research and Quality (R18 HS027960). Sara Vazquez disclosures: Royalties from Up to Date. Darren Triller is Anticoagulation Forum staff and has no funding relationships to disclose